Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1997-01-29
1999-11-02
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
424 941, 4242441, 424 9463, 4241841, 435195, 435220, 530350, A61K 3902, A61K 3843, C12N 952, C12N 914
Patent
active
059765429
ABSTRACT:
The invention relates to an isolated nucleic acid encoding Streptococcus pneumoniae IgA protease and an isolated polypeptide comprising Streptococcus pneumoniae IgA protease and methods of use thereof.
REFERENCES:
patent: 4879213 (1989-11-01), Fox et al.
Paton et al. Ann. Rev. Microbiol. 1993, 47, 89-115.
Kilian. J. Immunol. 1988 vol. 124, No. 6, 2596-2600.
Burgess et al J. Cell. Biol. 1990 vol. 111, 2129-2138.
Lazar et al. Mol. Cell. Biol. 1988 vol. 8, No. 3, 1247-1252.
Plotkin et al (ed.) Published by W.B. Saunders Co., Philadelphia, 1988, p. 571.
Lacks et al., 1960, Biochim Biophys. Acta. 39:508-517.
Tiraby et al., 1973, Proc. Natl. Acad. Sci. USA 70:3541-3545.
Plaut et al., 1975, Science 190:1103-1105.
Sanger et al., 1977, Proc. Natl. Acad. Sci. USA 74:5463-5467.
Kilian et al., 1979, Infect. Immun. 26:143-149.
Male, 1979, Infect. Immun. 62:254-261.
Towbin et al., 1979, Proc. Natl. Acad. Sci. USA 76:4350-4354.
Kyte et al., 1982, J. Mol. Biol. 157:105-132.
Bricker et al., 1983, Proc. Natl. Acad. Sci. USA 80:2681-2685.
Plaut et al., 1983, Ann. Rev. Microbiol. 37:603-622.
Devereux et al., 1984, Nucl. Acids. Res. 12:387-395.
Koomey et al., 1984, Immun. 43:101-107.
Mortensen et al., 1984, Infect. Immun. 45:550-557.
Moxon et al., 1984, J. Clin. Invest. 73:298-306.
Achen et al., 1986, Gene 45:45-49.
Kett et al., 1986, J. Immunol. 136:3631-3635.
Monod et al., 1986, J. Bacteriol. 167:138-147.
von Heijne, 1986, Nucl. Acids Res. 14:4683-4690.
Pohlner et al., 1987, Nature (London) 325:458-462.
Takeshita et al., 1987, Gene 61:63-74.
Gilbert et al., 1988, Infect. Immun. 56:1961-1966.
Harlow et al., 1988, In: Antibodies, a Laboratory Manual, Cold Spring Harbor, NY. (Too voluminous to submit).
Jongeneel et al., 1989, FEBS Lett. 242:196-203.
Poulsen et al., 1989, Infect. Immun. 57:3097-3105.
Sambrook et al., 1989, "Molecular Cloning: a Laboratory Manual" Cold Spring Harbor, New York. (Too voluminous to submit).
Altschul et al., 1990, J. Mol. Biol. 215:403-410.
Fischetti et al., 1990, Mol. Micro biol. 4:1603-1605.
Klugman, 1990, Clin. Microbiol. Rev. 3:171-196.
Saraste et al., 1990, Trends Biochem. Sci. 15:430-434.
Vallee et al., 1990, Proc. Natl. Acad. Sci. USA 87:220-224.
Gilbert et al., 1991, Infect. Immun. 59:7-17.
Pearce et al., 1993, Mol. Microbiol. 9:1037-1050.
Tuallion et al., 1993, Proc. Natl. Acad. Sci. USA 90:3720.
Weiser et al., 1994, "Phase Variation in Pneumococcal Opacity: Relationship Between Colonial Morphology and Nasopharyngeal Colonization", Infect. Immun. 62(6):2582-2589.
Berry et al., "Effect of Defined Point Mutations in the Pneumolysin Gene on the Virulence of Streptococcus Pneumoniae", Infect. Immun. 63(5):1969-1974.
Gilbert et al,. 1995, Infn. Immun. 63:2682-2688.
Gordon and Breech, 1995, In: The Antibodies 1:.
Lomholt et al., 1995, Infect. Immun. 63:4238-4243.
Schneewind et al., 1995, Science 268:103-106.
Slauja et al., 1995, Mol. Microbiol. 16:215-227.
Tuomanen et al., 1995, New Engl. J. Med. 332:1280-1284.
Weiser et al., 1995, Mol. Microbiol. 17:555-564.
Qui et al., 1996, Infect. Immun. 64:933-937.
Weiser et al., 1996, Infect. Immun. 64:2240-2245.
Gilbert-Rothstein Joanne V.
Plaut Andrew G.
Weiser Jeffrey N.
Caputa Anthony C.
New England Medical Center
Weatherspoon John K.
LandOfFree
Compositions and methods for treatment of streptococcus pneumoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treatment of streptococcus pneumoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treatment of streptococcus pneumoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2131547